Leishmania donovani BPK282A1 complete genome, chromosome 3.
Eukaryota; Euglenozoa; Kinetoplastida; Trypanosomatidae; Leishmaniinae; Leishmania.
Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance
Submitted (30-MAR-2018) National Center for Biotechnology Information, NIH, Bethesda, MD 20894, USA
Submitted (25-JAN-2011) Aslett M., Pathogen Sequencing Unit, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, Cambridgeshire CB10 1SA, UNITED KINGDOM
PROVISIONAL REFSEQ: This record has not yet been subject to final\nNCBI review. The reference sequence is identical to FR799590.\nData release policy http://www.sanger.ac.uk/legal/#t_2.\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: INSDC submitter\nAnnotation Status :: Full annotation\nAnnotation Pipeline :: Eukaryotic Annotation Propagation Pipeline\n##Genome-Annotation-Data-END##
D-3-phosphoglycerate dehydrogenase-like protein
2-aminoethylphosphonate:pyruvateaminotransferas e-like protein
cytochrome c oxidase assembly protein, putative
ATP-binding cassette protein subfamily F, member 1, putative
delta-1-pyrroline-5-carboxylate dehydrogenase, putative
long chain fatty Acyl CoA synthetase, putative
60S acidic ribosomal protein P2, putative
phosphate-Repressible Phosphate Permease-like protein
26S protease regulatory subunit, putative
cytochrome c oxidase copper chaperone, putative
serine/threonine-protein kinase, putative
6-phosphofructo-2-kinase/fructose-2,6-biphospha ta se,putative
elongation initiation factor 2 alpha subunit, putative